Related Articles
p53-deficient cells display increased sensitivity to anthracyclines after loss of the catalytic subunit of the DNA-dependent protein kinase
PARP inhibitor resistance and TP53 mutations in patients treated with olaparib for BRCA-mutated cancer: Four case reports
Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents
Mutations in DNA mismatch repair genes: Implications for DNA damage signaling and drug sensitivity (Review)
Nicotinamide sensitizes human breast cancer cells to the cytotoxic effects of radiation and cisplatin